New hope for advanced prostate cancer: drug combo trial launches
NCT ID NCT07590934
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study is testing two experimental drugs (AZD9574 and AZD2265) together in people with metastatic prostate cancer that has spread beyond the prostate. The goal is to see if the combination is safe and can shrink tumors or lower PSA levels. About 152 adults whose cancer has not responded to standard treatments will take part. The trial is not yet recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGEncino, California, 91436, United States
-
Research Site
RECRUITINGSouth Pasadena, California, 91030, United States
-
Research Site
RECRUITINGMiami, Florida, 33165, United States
-
Research Site
NOT_YET_RECRUITINGTampa, Florida, 33612, United States
-
Research Site
NOT_YET_RECRUITINGMetairie, Louisiana, 70006, United States
-
Research Site
NOT_YET_RECRUITINGMinneapolis, Minnesota, 55455, United States
-
Research Site
NOT_YET_RECRUITINGOmaha, Nebraska, 68130, United States
-
Research Site
NOT_YET_RECRUITINGNew York, New York, 10065, United States
-
Research Site
NOT_YET_RECRUITINGPortland, Oregon, 97239, United States
-
Research Site
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
-
Research Site
NOT_YET_RECRUITINGNorth Adelaide, 5000, Australia
-
Research Site
NOT_YET_RECRUITINGEssen, 45147, Germany
-
Research Site
NOT_YET_RECRUITINGJena, 07747, Germany
-
Research Site
NOT_YET_RECRUITINGRostock, 18057, Germany
-
Research Site
NOT_YET_RECRUITINGTübingen, 72076, Germany
-
Research Site
NOT_YET_RECRUITINGBergamo, 24127, Italy
-
Research Site
NOT_YET_RECRUITINGMeldola, 47014, Italy
-
Research Site
NOT_YET_RECRUITINGMilan, 20133, Italy
-
Research Site
NOT_YET_RECRUITINGMilan, 20141, Italy
-
Research Site
NOT_YET_RECRUITINGRoma, 00168, Italy
-
Research Site
NOT_YET_RECRUITINGSeoul, 03080, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 03722, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 06351, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 06591, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 5505, South Korea
-
Research Site
NOT_YET_RECRUITINGBarcelona, 08028, Spain
-
Research Site
NOT_YET_RECRUITINGL'Hospitalet de Llobregat, 08908, Spain
-
Research Site
NOT_YET_RECRUITINGMadrid, 28031, Spain
-
Research Site
NOT_YET_RECRUITINGMadrid, 28041, Spain
-
Research Site
NOT_YET_RECRUITINGPamplona, 31008, Spain
-
Research Site
NOT_YET_RECRUITINGFulham, SW3 6JJ, United Kingdom
-
Research Site
NOT_YET_RECRUITINGGuildford, CU2 7XX, United Kingdom
-
Research Site
NOT_YET_RECRUITINGLondon, WC1E 6DB, United Kingdom
-
Research Site
NOT_YET_RECRUITINGNewcastle upon Tyne, NE7 7DN, United Kingdom
-
Research Site
NOT_YET_RECRUITINGOxford, OX3 7LE, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blast of testosterone shrink hard-to-treat prostate cancer?
- Can a Two-Drug attack stall resistant prostate cancer?
- A PET scan and a blood test may predict which men with advanced prostate cancer will benefit from targeted therapy
- Can a new daily pill slow advanced prostate cancer?
- Radiation plus hormone therapy may slow resistant prostate cancer
- Targeted radiation zaps prostate cancer cells in new trial